Poirier Michael S. (CIK 0001812504)

Latest company ownership

Shares held
375,000
Last filed at
Aug 4, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 22, 2022 Jun 22, 2022 Qualigen Therapeutics, Inc. CEO Buy 91.3 +30,000 16.65% $17.1K
Apr 20, 2021 Apr 21, 2021 Qualigen Therapeutics, Inc. CEO Buy 86.3 +11,005 6.50% $19.8K